News

AbstractHereditary transthyretin amyloidosis (ATTRv), the most common form of hereditary amyloidosis, results from autosomal dominant mutations in the TTR gene.…

AbstractBackground Bone-avid tracer myocardial scintigraphy for the diagnosis of transthyretin amyloid cardiomyopathy (ATTR-CM) has traditionally employed imaging…

With the determination of the President no. 655/2026 (Rome, 21 May 2026; published in the Official Gazette on 28 May 2026), the Italian Medicines Agency extended…

AbstractIntroductionTransthyretin amyloid cardiomyopathy (ATTR-CM) is a progressive disease predominantly affecting older men and is associated with increasing care…

AbstractBackground Transthyretin amyloid cardiomyopathy (ATTR‐CM) is a rare, life‐threatening form of restrictive cardiomyopathy. Access to cardiology providers and…

AbstractBackgroundThe Mayo transthyretin amyloid cardiomyopathy (ATTR-CM) and AMY scores were developed to identify patients at risk for ATTR-CM. However, both were…

For women living with ATTR-Cardiac Amyloidosis (ATTR-CM), a serious heart disease that worsens over time, the path to diagnosis is rarely straightforward. Symptoms…

AbstractSystemic light chain (AL) amyloidosis is a rare, acquired protein misfolding disorder characterized by extracellular deposition of misfolded immunoglobulin…

AbstractBackgroundTransthyretin amyloid cardiomyopathy (ATTR-CM) is a progressive, often fatal disease caused by transthyretin (TTR) tetramer destabilization,…

Study OverviewBrief SummaryCardiac amyloidosis (CA) is an infiltrative disease characterized by deposits of amyloid proteins of genetic or acquired origin (often in…